OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR

From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer

Expert Discussion at COGC 2026: The Right First Investments in Precision Oncology

London Global Cancer Week 2026: Highlights From November 2–4

BeOne Medicines’ Zanubrutinib Combination Gains FDA Priority Review for First-Line Mantle Cell Lymphoma

Oncology News, Insights, Stories by OncoDaily

LungÕ 2026 – Virtual Global Congress on Lung Oncology
Projects

LungÕ 2026 – Virtual Global Congress on Lung Oncology

ASTRIDE
Dialogues

ASTRIDE Bridges the Gap: Serplulimab Matches 32% Two-Year Survival in U.S. Patients with Small Cell Lung Cancer

Daniel Malarek
Dialogues

Daniel Malarek and a Wish for Oncology: A Future Where Breakthroughs Reach Every Patient

London Global Cancer Week 2026: What’s Coming on November 5

Muscle-Invasive Bladder Cancer: Outcomes of Patients Who Declined Radical Cystectomy

Advanced Biliary Tract Cancer: Real-World Outcomes of First-Line Chemoimmunotherapy and Subsequent Targeted Therapy

Merck KGaA to Divest CDMO Business to Lonza

Christian Ntizimira: Why We Should Stop Saying 'End-of-Life Care' and Start Saying 'Life Until the End'

Neoadjuvant Carboplatin Improves Event-Free Survival in Early TNBC: Pooled Analysis of Three Randomized Trials Strengthens the Evidence

Nicholas Hornstein: Could Botensilimab and Balstilimab Change the Future of MSS Colorectal Cancer?

Voices
Parker Institute

Parker Institute to Showcase Advances in Cancer Vaccines, Cell Therapies, and Next-Generation Immunotherapies at SITC 2026

Julie S. Torode Highlights the Importance of Sharing the African Cancer Community’s Views on Palliative Care

Shubh Goel։ Calling on the Entire Healthcare Ecosystem to Rally Behind the Lung Cancer Community

Amanda Pullinger: What’s Happening This November for Gastric Cancer Awareness Month?

Seattle Children's Researchers Are Helping Rewrite the Future of Pediatric Cancer Care Through Engineered Cell Therapies

Gilberto Lopes: How Decades of Research Transformed the Treatment of Lung Cancer?

Anne Tsao: UT MD Anderson Seeks New Chair of Health Services Research

FDA Approvals
CLL/SLL Pirtobrutinib

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

24th Annual School of Breast Oncology 2026

Physicians’ Education Resource

05 Nov
Breast Oncology

SIOG 2026 Annual Conference

International Society of Geriatric Oncology (SIOG)

05 Nov
SIOG 2026 Annual Conference

The CAMO 2026 Annual Scientific Meeting

Canadian Association of Medical Oncologists (CAMO)

05 Nov
CAMO 2026

The 2026 NANETS Multidisciplinary NET Medical Symposium

North American Neuroendocrine Tumor Society (NANETS)

05 Nov
NANETS

The 2026 Global Colorectal Cancer Congress

Global Colon Cancer Association (GCCA)

05 Nov
Global Colorectal Cancer Congress

The 2026 AAADV Workshop

AAADV Workshop Foundation

05 Nov
AAADV Workshop

10th Advances in Colorectal Oncology: Shaping the Future of Multidisciplinary Care

Memorial Sloan Kettering Cancer Center (MSK)

05 Nov
Advances in Colorectal Oncology

Mayo Clinic Multidisciplinary Update in Breast Disease 2026

Mayo Clinic

05 Nov
Hepato-Pancreatico-Biliary Cancer

The Caring for the Cancer Patient 2026

Mayo Clinic

05 Nov
Hepato-Pancreatico-Biliary Cancer

The XXVII Brazilian Congress of Clinical Oncology 2026

Brazilian Society of Clinical Oncology (SBOC)

05 Nov
Brazilian Congress

LungÕ 2026 – Virtual Global Congress on Lung Oncology

OncoDaily

05 Nov
LungÕ 2026

2026 NNECOS Annual Meeting and Palliative Care Symposium

Northern New England Clinical Oncology Society (NNECOS)

06 Nov
Best Oncology Practice

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment

KEYFORM-007: Dual PD-1/LAG-3 Blockade in MSS Colorectal Cancer

Agentic AI for Immune-Related Adverse Event Detection in Cancer Immunotherapy

Can the Tumor’s Own B Cells Reveal the Next Immunotherapy Target?

ESMO 2026: The Key Pembrolizumab Trials to Know

ESMO 2026: What’s New in Melanoma Immunotherapy?

Gastrointestinal-Oncology
PRECEDE

PRECEDE Study: Pancreatic Imaging Findings During Surveillance in BRCA1, BRCA2, ATM, and PALB2 Heterozygotes

Advanced Biliary Tract Cancer: Real-World Outcomes of First-Line Chemoimmunotherapy and Subsequent Targeted Therapy

NICHE-2: Long-Term Survival Outcomes With Neoadjuvant Immunotherapy in dMMR Colon Cancer

UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer

10 Must-Read Posts in GI Oncology This Week

Top Gastroesophageal Cancer Updates From ESMO 2026

FOLFOX Chemotherapy: What It Is, Drugs, Uses, Cycles, and Side Effects

Breast-Oncology
OPTIMA

From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer

Neoadjuvant Carboplatin Improves Event-Free Survival in Early TNBC: Pooled Analysis of Three Randomized Trials Strengthens the Evidence

SABCS 2026: The Top 10 Breast Cancer Studies to Watch for Potential Practice-Changing Results

Trastuzumab Deruxtecan Secures EU Approval for Residual HER2-Positive Early Breast Cancer Following DESTINY-Breast05 Survival-Free Disease Benefit

A New Chance to Prevent Recurrence: EU Approves Trastuzumab Deruxtecan for HER2-Positive Early Breast Cancer

Biomarker Landscape of ADCs and Bispecific Antibodies in Breast Cancer: The 2026 Clinical Trial Breakthroughs and Future of Precision Treatment

Inflammatory Breast Cancer in 2026: Evolving Diagnostic Criteria, Modern Trimodality Treatment, and the Challenge of Improving Survival

Lung-Oncology
Ivonescimab

Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR

LungÕ 2026: Integrating Care and Advancing Treatment for Locally Advanced Lung Cancer

Tarlatamab-Associated Neurotoxicity in SCLC: New Study Identifies TIAN in Patients With Brain Metastases

Neoadjuvant Immunotherapy Linked to Improved Five-Year Survival in Resected NSCLC: Real-World Study Supports Long-Term Benefit Without Increased Surgical Morbidity

Biomarker Landscape of ADCs and Bispecific Antibodies in Lung Cancer: The 2026 Clinical Trial Evidence and Future of Precision Treatment

ASCO 2026.3.4 Living Guideline: Lorlatinib Takes Priority in First-Line ALK-Positive NSCLC After Landmark Seven-Year CROWN Results

KEYNOTE-867 Phase III: Pembrolizumab Plus SBRT Fails to Improve Event-Free Survival and Increases Severe Toxicity in Early-Stage NSCLC

OncoDaily TV
Dr Gevorg Tamamyan

Dr Gevorg Tamamyan Welcomes Prof Cesaltina Lorenzoni, President of AORTIC, to the International Advisory Board of WHO Director-General Campaign

Dr Gevorg Tamamyan

Mongolia’s Former Minister of Health Dr Chinburen Jigjidsuren Will Join the International Advisory Board of Dr Gevorg Tamamyan’s WHO DG Campaign

Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Not To Miss
SIOG 2026

SIOG 2026 SPARC Roundtable: Alleviating the Burden of Cancer Care for Older Adults

London Global Cancer Week 2026: Highlights From November 2–4

London Global Cancer Week 2026: What’s Coming on November 5

BeOne Medicines’ Zanubrutinib Combination Gains FDA Priority Review for First-Line Mantle Cell Lymphoma

Dren Bio Raises $350M to Advance Dibotatug Toward Commercialization

London Global Cancer Week 2026: What's Coming on November 4

Natera’s Signatera MRD Test Gains Broader Medicare Coverage for Liver Cancer Surveillance

OncoGrants
RSNA

RSNA Research Seed Grant 2027

CAP Foundation

CAP Foundation Equity and Equality in Diagnostics Award

World Cancer Research Fund

World Cancer Research Fund 2026–2027 Regular Grant Programme

Fanconi Anemia

ACS–Fanconi Cancer Foundation Discovery Boost Grant: Up to $297,000 for Fanconi Anemia-Associated Cancer Research

Emerging Technologies

NCI Advanced Development and Validation of Emerging Technologies for Cancer Research 2026

IGNITE Award

Cancer Research Institute — IGNITE Award 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Vinod Balachandran

Vinod Balachandran

Oncologists Location New York, USA
Javier David Benítez

Javier David Benítez

Oncologists Location Elche, Spain
Sara Tolaney

Sara Tolaney

Oncologists Location Boston, USA
Kathleen Schmeler

Kathleen Schmeler

Oncologists Location Houston, USA
Karen Knudsen

Karen Knudsen

Oncologists Location San Francisco, USA
Anjaly Mohan

Anjaly Mohan

Oncologists Location Thiruvananthapuram, India
Thaís Santana

Thaís Santana

Oncologists Location Goiânia, Brazil
Eric Bernicker

Eric Bernicker

Oncologists Location Denver, USA

Drugs Atlas
Pertuzumab (Perjeta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Pertuzumab (Perjeta) Nov 3, 2026 9:23 am
Trastuzumab (Herceptin): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Trastuzumab (Herceptin) Nov 2, 2026 5:11 pm
Ofatumumab (Arzerra, Kesimpta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Ofatumumab (Arzerra, Kesimpta) Nov 1, 2026 1:25 am
Obinutuzumab (Gazyva): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Obinutuzumab (Gazyva; Gazyvaro) Nov 1, 2026 1:23 am
Sotorasib (Lumakras; AMG 510): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in KRAS G12C-Mutated Lung and Colorectal Cancer Sotorasib (Lumakras; AMG 510) Oct 31, 2026 6:38 am
Rituximab (Rituxan; MabThera): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in B-Cell Malignancies and Autoimmune Diseases Rituximab (Rituxan; MabThera) Oct 31, 2026 6:37 am
Adagrasib (Krazati; MRTX849): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in KRAS G12C-Mutated Cancers Adagrasib (Krazati; MRTX849) Oct 30, 2026 12:57 am
Infigratinib (Truseltiq; BGJ398): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in FGFR2-Rearranged Cholangiocarcinoma Infigratinib (Truseltiq; BGJ398) Oct 30, 2026 12:56 am
Futibatinib (Lytgobi): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in FGFR2-Rearranged Intrahepatic Cholangiocarcinoma Futibatinib (Lytgobi) Oct 28, 2026 1:27 pm
Pemigatinib (Pemazyre): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in FGFR-Driven Cancers and Myeloid/Lymphoid Neoplasms Pemigatinib (Pemazyre) Oct 28, 2026 1:02 am

OncoDaily Magazine

New Paper Alert
Luis Álvarez-Vallina

Luis Álvarez-Vallina’s STAb-T Research Takes the Spotlight in Advanced Science

Jia Liu

Jia Liu: Are We Measuring the Full Benefit of ADCs in Cancer Treatment?

Narjust Florez

Narjust Florez: TKIs in Pregnancy for Lung Cancer

Stephen Liu

Stephen Liu: TKI-Based Induction Therapy Enables Surgery in Initially Unresectable EGFR-Mutant NSCLC

Partha Basu

Partha Basu's New Paper on the Potential of Handheld Ultrasound by Trained Nonradiologists

Gilberto Lopes

Gilberto Lopes Highlights Critical Links Between Lung Cancer Stigma, Depression and Anxiety

OncoDaily Medical Journal

GU Oncology

10.69690/ODMJ-001-1026-8269

Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis
Original Research

Pediatric Oncology

10.69690/ODMJ-001-1026-8309

Limited Prognostic Value of Baseline Curie Score in Children with High-Risk Neuroblastoma Treated with Contemporary Multi-modal Therapy: A Single-Center Retrospective Cohort Study
Original Research

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews